Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Increases Revolving Credit Facility to $700M

NEW YORK (GenomeWeb News) – PerkinElmer has entered into a second amended and restated unsecured revolving credit facility increasing the total the firm may borrow up to $700 million from a previous amount of $500 million.

PerkinElmer, Wallac Oy, and PerkinElmer Health Sciences are listed as the borrowers. The agreement was signed with Bank of America as administrative agent; Swing Line Lender and other lenders; Barclays Capital as syndication manager; and Merrill Lynch, Pierce, Fenner & Smith, and Barclays listed as joint lead arrangers and joint book managers.

The $700 million credit facility runs through Dec. 16, 2016.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.